We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Antigenics Reports Positive Trial Results for Cancer Vaccine
Antigenics Reports Positive Trial Results for Cancer Vaccine
October 10, 2005
Biotechnology firm Antigenics is preparing to launch a pivotal trial for its cancer vaccine Oncophage — a move that comes in the wake of preliminary data from a late-stage clinical trial that showed the drug extended the survival of advanced skin cancer patients.